Advertisement

Topics

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

2017-07-24 12:11:38 | BioPortfolio

Published on BioPortfolio: 2017-07-24T12:11:38-0400

Clinical Trials [373 Associated Clinical Trials listed on BioPortfolio]

Dual Algorithm Post Market Clinical Study

The purpose of this study is to assess the validity and reproducibility of the MP Diagnostics HTLV Blot 2.4 in blood specimens testing repeat reactive (RR) on the first FDA licensed screen...

HTLV-1 Carriers and HTLV-1 Associated Illnesses in Blood Donors in Jamaica

RATIONALE: Collecting information about HTLV-1 carriers and HTLV-1 associated illnesses in blood donors in Jamaica may help doctors learn more about these diseases. PURPOSE: This clinical...

A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)

The objective of this study is to assess the efficacy and safety of KW-0761 after intravenous injections in subjects with HTLV-1 associated myelopathy (HAM) in Japan.

Immunotherapy of Natural Killer(NK) Cells in Human T Lymphotropic Virus Type 1(HTLV-1) Associated Myelopathy(HAM)

HTLV-1 Associated Myelopathy is a chronic disease of the spinal cord, caused by a virus called human T lymphotropic virus type 1(HTLV−1). Natural Killer cells provide rapid responses...

Evaluation of InnoLIA HTLV I/II Score

The InnoLIA HTLV I/II Score is an in vitro diagnostic test for confirmation of antibodies to human T-cell lymphotropic virus (HTLV) type I and type II in human blood samples. It is intend...

PubMed Articles [5042 Associated PubMed Articles listed on BioPortfolio]

Detection of HTLV-1 proviral DNA in BM mononuclear cells and cultured mesenchymal stromal cells isolated from patients with HTLV-1 infection.

The bone marrow (BM) biology during HTLV-1 infection is obscure. In this study, we investigated BM mononuclear cells and mesenchymal stromal cells (MSC) from HTLV-1 asymptomatic and symptomatic indivi...

Revisiting human T-cell lymphotropic virus types 1 and 2 infections among rural population in Gabon, central Africa thirty years after the first analysis.

HTLV-1 infection is considered as highly endemic in central Africa. Thirty years ago, a first epidemiological study was performed in Gabon, central Africa, and revealed that the prevalence varied from...

Re-emergence of human T-lymphotropic viruses in West Africa.

Human T-lymphotropic viruses (HTLV) are Deltaretroviruses that infect millions of individuals worldwide via the same transmission routes as HIV. With the aim of exposing the possible re-emergence of H...

Spinal cord hypometabolism associated with infection by human T-cell lymphotropic virus type 1(HTLV-1).

HTLV-1 infection is endemic in Brazil. About 1 to 2% of the Brazilian population is estimated to be infected, but most infected HTLV-1 individuals do not know about their own infection, which favors t...

Risk factors for HTLV-1 infection in Central Africa: A rural population-based survey in Gabon.

Human T-Lymphotropic Virus type 1 (HTLV-1) is a human oncoretrovirus that infects at least 5 to 10 million people worldwide and is associated with severe diseases. Africa appears as the largest HTLV-1...

Medical and Biotech [MESH] Definitions

Infections caused by the HTLV or BLV deltaretroviruses. They include human T-cell leukemia-lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED).

Antibodies reactive with the HTLV-II ANTIGENS.

Antibodies reactive with the HTLV-I ANTIGENS.

Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1.

Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 2.

More From BioPortfolio on "MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial